KERYX BIOPHARMACEUTICALS INC

CUSIP: 492515101 Class: COMMON STOCK

MetLife Investment Management, LLC's Holding History (CIK: 0001529735)

Note: Option positions (PUT/CALL) are excluded.

Q3 2018
Shares 5,191 Value ($000) $18 Avg Close — Range —
Q2 2018
Shares 40,309 Value ($000) $152 Avg Close — Range —
Q1 2018
Shares 40,309 Value ($000) $165 Avg Close — Range —
Q4 2017
Shares 40,309 Value ($000) $187 Avg Close — Range —